scholarly journals Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study

2018 ◽  
Vol 18 (6) ◽  
pp. 1435-1446 ◽  
Author(s):  
Long-Bin Jeng ◽  
Sung Gyu Lee ◽  
Arvinder Singh Soin ◽  
Wei-Chen Lee ◽  
Kyung-Suk Suh ◽  
...  
2010 ◽  
Vol 16 (12) ◽  
pp. 1379-1385 ◽  
Author(s):  
Taku Iida ◽  
Toshimi Kaido ◽  
Shintaro Yagi ◽  
Atsushi Yoshizawa ◽  
Koichiro Hata ◽  
...  

2013 ◽  
Vol 98 (4) ◽  
pp. 428-431
Author(s):  
Hironori Hayashi ◽  
Hiroyuki Takamura ◽  
Takumi Taniguchi ◽  
Shin-ichi Nakanuma ◽  
Hisatoshi Nakagawara ◽  
...  

Abstract Blood purification therapy is indispensable for liver transplant recipients. The case of a living donor liver transplant recipient who represented graft insufficiency and was supported by novel blood purification “plasma diafiltration” immediately after operation is presented. A 60-year-old woman was referred for living donor liver transplant because of liver cirrhosis due to hepatitis C. Elective living donor liver transplant was performed, but the graft was small for size. Thus, the signs of graft insufficiency appeared immediately after the operation, and plasma diafiltration was used as a bridge to graft regeneration. After plasma diafiltration was started, the recipient recovered promptly, and withdrawal was performed 35 hours after induction without any complications. Plasma diafiltration is a useful and safe liver support for liver transplant recipients, including immediately after liver transplantation.


Sign in / Sign up

Export Citation Format

Share Document